P2RY12: P2Y purinoceptor 12
A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.
Receptor for ADP and ATP coupled to G proteins that inhibit the adenylyl cyclase second messenger system.
- Drugs that act on it: 8
- With a US drug page: 4
- Type: Protein
Drugs That Act on It
Approved and clinical-stage drugs ChEMBL records for this target; those with a US approval link to their page| Cangrelor | Approved | Purinergic receptor P2Y12 antagonist | Antagonist | — |
| Prasugrel | Approved | Purinergic receptor P2Y12 antagonist | Antagonist | Boxed warning |
| Ticagrelor | Approved | Purinergic receptor P2Y12 negative allosteric modulator | Negative allosteric modulator | Boxed warning |
| Ticlopidine | Approved | Purinergic receptor P2Y12 antagonist | Antagonist | Boxed warning |
| Clopidogrel | — | Purinergic receptor P2Y12 antagonist | Antagonist | Boxed warning |
| Elinogrel | — | Purinergic receptor P2Y12 antagonist | Antagonist | — |
| Regrelor | — | Purinergic receptor P2Y12 antagonist | Antagonist | — |
| Selatogrel | — | Purinergic receptor P2Y12 antagonist | Antagonist | — |
Diseases Most Associated With It
Open Targets association score, 0 to 1; all associations- Platelet-type bleeding disorder 8
- 0.73
- Stroke disorder
- 0.61
- Coronary artery disorder
- 0.60
- Peripheral vascular disease
- 0.60
- Angina unstable
- 0.57
- Recurrent thrombophlebitis
- 0.55
- Thrombotic disease
- 0.54
- Angina pectoris
- 0.51
Drugs and mechanisms are from ChEMBL CHEMBL2001 (CC BY-SA 3.0). Gene name, function (UniProt Q9H244, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets